Plasma Fibrinogen Level Is an Important Determinant of Prolonged Euglobulin Clot Lysis Time in Hemodialysis Patients

Abstract

The euglobulin clot lysis time (ECLT), a traditional measure of plasminogen activation, directly depends on plasma fibrinogen (FBG) level. This fact was neglected in studies concluding that prolonged ECLT in chronic hemodialysis (HD) patients pointed exclusively to impaired fibrinolysis. We studied the relations between ECLT and plasma FBG levels in HD patients in relation to certain hepatic and inflammatory markers. Median ECLT of 320 minutes (range, 150 to 620 minutes) and plasma FBG of 306 mg/dL (range, 171 to 553 mg/dL) were higher in 75 HD patients than in 60 healthy controls (Mann-Whitney p < 0.0001). There were positive associations between these parameters both in the patients (Spear-man p = 0.273, p = 0.018) and the controls (p= 0.672, p < 0.0001). The FBG-corrected ECLT (plasma FBG/ECLT) (in mg/min x dL]) in the patients (0.92 [range, 0.47 to 2.43]) was not different (p = 0.065) from that in the controls (1.08 [0.58 to 1.67]). In the patients, serum alanine aminotransferase inversely correlated with ECLT (p = -0.306, p = 0.008) and FBG (p = -0.310, p = 0.007). whereas serum C-reactive protein was associated positively with these variables (p = 0.383, p = 0.0007: p = 0.477. p <0.0001, respectively). The FBG-corrected ECLT was not related to either marker. In conclusion, increased plasma FBG level, a continuum between liver dysfunction and stimulation by chronic inflammation, is an important determinant of prolonged ECLT in HD patients. The FBG-corrected ECLT value suggests that baseline activation of fibrinolysis is normal in these patients, and that this simple index could be useful in its laboratory assessment.

Keywords

Euglobulin clot lysis time Fibrinogen Hemodialysis.

References

Bockenstedt PL Laboratory methods in hemostasis. In: Loscalzo J , Schafer AI. eds. Thrombosis and Hemorrhage. Boston: Blackwell Scientific Publications, 1994:455.

Malyszko J. , Malyszko JS , Pawlak D. , et al. Hemostasis. platelet function and serotonin in acute and chronic renal failure. Thromb 3. Res 1996;83:351.

Ito T. , Niwa T. , Matsui E. Fibrinolytic activity in renal disease. Clin Chim Acta 1972,36:145.

Hong SY , Yang DH Fibrinolytic activity in end-stage renal failure. Nephron 1993;63:188.

Stenver D. , Jeppesen L. , Nielsen B. , et al. The effect of erythropoietin on platelet function and fibrinolysis in chronic renal failure. Int J Artif Organs 1994;17:141.

Malyszko J. Malysxko JS , Borawski J. , et al. A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy. Thromb Res 1995;77:133.

Malyszko J. , Malyszko JS , Pawlak K. , et al. The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients. Transplantation 1996;662:828.

Hunt BJ , Segal H. , Yacoub M. Hemostatic changes in heart transplant recipients and their relationship to accelerated coronary sclerosis. Transplantation 1993;55:309.

el Khawand C. , Jamart J. , Donckiert J. , et al. Haemostasis variables in type I diabetic patients without demonstrable vascular complications . Diabetes Care 1993; 18:1137.

10.

Haverkate F. , Thompson SG , Duckert F. Haemostasis factors in angina pectoris: relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group. Thromb Haemost 1995,73:561.

11.

Lowe Gdo , Prentice Crm. The laboratory investigation of fibrinolysis. In: Thomson JM , ed. Blood Coagulation and Haemostasis. A Practical Guide. Edinburgh: Churchill Livingstone , 1980:222.

12.

Urano T. , Sakakibara K. Rydzewski A , et al. Relationship between eugiobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor I. Thromb Haemost 1990;63:82.